Literature DB >> 14990977

Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.

M S Hardianti1, E Tatsumi, M Syampurnawati, K Furuta, K Saigo, Y Nakamachi, S Kumagai, H Ohno, S Tanabe, M Uchida, N Yasuda.   

Abstract

Activation-induced cytidine deaminase (AID) is required for somatic hypermutation (SHM) and class switch recombination (CSR) of the immunoglobulin (Ig) gene. AID has been reported to be specifically expressed in the germinal center (GC). Follicular lymphoma (FL) cells are known to be exposed to GC reaction, as characterized by a high degree of SHM with some heterogeneity in terms of intraclonal microheterogeneity and antigen selection. The heterogeneity of SHM pattern in FL intrigued us to investigate the AID expression. AID expression was investigated in 19 FL materials consisting of 15 cases of FL fresh cells and four cell lines. In all, 10 fresh cells and three cell lines expressed AID, but the others did not. SHM was investigated in 12 fresh cells and four cell lines. The ongoing mutation was significantly different between AID-positive and AID-negative FL fresh cells (unpaired Student's t-test, P=0.047). Ongoing mutation was not seen in any of the cell lines. AID expression was associated with the ongoing mutation in FL fresh cells (two-tailed Pearson's coefficient correlation, r=0.899, P=0.01). The switch off of AID expression may start in the B-lineage differentiation stage counterpart of FL after optimizing SHM, indicated by the cessation of the ongoing mutation in AID-negative FL fresh cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990977     DOI: 10.1038/sj.leu.2403323

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.

Authors:  Martin Wartenberg; Peter Vasil; Christian Meyer zum Bueschenfelde; German Ott; Andreas Rosenwald; Falko Fend; Marcus Kremer
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 3.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.

Authors:  Sachini U Siriwardena; Kang Chen; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2016-09-01       Impact factor: 60.622

4.  Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy.

Authors:  Kiyoko Kawamura; Akihiko Wada; Ji-Yang Wang; Quanhai Li; Akihiro Ishii; Hideki Tsujimura; Toshiyuki Takagi; Makiko Itami; Yuji Tada; Koichiro Tatsumi; Hideaki Shimada; Kenzo Hiroshima; Masatoshi Tagawa
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-16       Impact factor: 4.553

5.  Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs.

Authors:  Jin-Qing Liu; Pramod S Joshi; Chuansong Wang; Hani Y El-Omrani; Yi Xiao; Xiuping Liu; John P Hagan; Chang-Gong Liu; Lai-Chu Wu; Xue-Feng Bai
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

6.  AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.

Authors:  Xiwen Gu; Carmen J Booth; Zongzhi Liu; Matthew P Strout
Journal:  Blood       Date:  2015-09-18       Impact factor: 22.113

7.  Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.

Authors:  Xiaosheng Wu; Jaime R Darce; Sook Kyung Chang; Grzegorz S Nowakowski; Diane F Jelinek
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

Review 8.  APOBEC3s: DNA-editing human cytidine deaminases.

Authors:  Tania V Silvas; Celia A Schiffer
Journal:  Protein Sci       Date:  2019-07-10       Impact factor: 6.993

Review 9.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

Review 10.  AID/APOBEC deaminases and cancer.

Authors:  Stefan Rebhandl; Michael Huemer; Richard Greil; Roland Geisberger
Journal:  Oncoscience       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.